Human Fungal Infections: Need to Improve Diagnosis with New Biomarkers Developed by Translational Research

Human Fungal Infections: Need to Improve Diagnosis with New Biomarkers Developed by Translational Research

The burden of invasive fungal disease (IFD) continues to increase as a result of improved medical  intervention and supportive care. The growing number of patients with a variety of risk factors (e.g. transplantation, chemotherapy, HIV infection, use of corticosteroids or new immunosuppressive agents) have caused an increase in incidence of invasive infections in recent years. Millions of individuals worldwide are affected or at risk and mortality is high.